Thibault Sottiaux helped make AI coding one of OpenAI’s fastest-growing businesses. Now he’s overseeing a sweeping overhaul of ChatGPT.

Take two, two years later. That’s the 2026 WWDC in a nutshell, at least for developers. And for consumers? If your Apple Watch is more than a few years old, it’s headed for retirement-and-replacement.

Whether it’s Ava (Hannah Einbinder) leveraging studio blackmail to force Deborah to make her the head writer of her late-night show or Louis (Jacob Anderson) slitting Lestat’s throat and leaving him ...

The annual Florida Python Challenge is a 10-day event to remove invasive Burmese pythons from the Everglades. Participants can win a share of $25,000 in prizes, including a $10,000 grand prize for ...

Luxury condos donning the names of world-renowned brands are taking over South Florida, but the buyers who have spent millions of dollars to fill them are starting to see the cracks — literally. In ...

It’s a tough job market for software engineering hopefuls. Tens of thousands of jobs cuts across the industry have increased competition for open spots. The rise of AI has spurred fears of cheating ...

Eli Lilly & Co. is buying three clinical-stage vaccine developers for as much as $3.8 billion, leveraging its obesity-fueled dominance to establish itself as a leader in other areas and become a major ...

Weight loss drugmaker Eli Lilly (LLY) on Tuesday announced a trio of deals worth up to nearly $4B to acquire three vaccine developers, Curevo, LimmaTech Biologics, and Vaccine Company, as part of a ...

Every year, hundreds of professional hunters, thrill-seekers, and curious amateurs descend on South Florida for the annual Florida Python Challenge — a 10-day competition aimed at removing invasive ...

Eli Lilly has splashed up to $3.8 billion on an infectious disease pipeline, acquiring Curevo, LimmaTech Biologics and Vaccine Company to extend its buying spree into viral and bacterial pathogen R&D.

Two Eli Lilly researchers at work. Lilly has agreed to acquire three privately-held developers vaccines for infectious diseases for a combined up to $3.83 billion cash, in deals intended to expand the ...